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Abstract
Background: Syphilis is a growing public health problem among men who have sex with men (MSM) globally.
Rapid and accurate detection of syphilis is vital to ensure patients and their contacts receive timely treatment and
reduce ongoing transmission.
Methods: We evaluated a PCR assay for the diagnosis of Treponema pallidum using swabs of suspected early
syphilis lesions in longitudinally assessed MSM.
Results: We tested 260 MSM for T pallidum by PCR on 288 occasions: 77 (26.7%) had early syphilis that was
serologically confirmed at baseline or within six weeks, and 211 (73.3%) remained seronegative for syphilis. Of 55
men with primary syphilis, 49 were PCR positive, giving a sensitivity of 89.1% (95% CI: 77.8%-95.9%) and a specificity
of 99.1% (95% CI: 96.5%-99.9%). Of 22 men with secondary syphilis, 11 were PCR positive, giving a sensitivity of 50%
(95% CI: 28.2%-71.8%) and a specificity of 100% (95% CI: 66.4%-71.8%). Of the 77 syphilis cases, 43 (56%) were HIV
positive and the sensitivity and specificity of the PCR test did not vary by HIV status. The PCR test was able to
detect up to five (10%) primary infections that were initially seronegative, including one HIV positive man with
delayed seroconversion to syphilis (72 to 140 days) and one HIV positive man who did not seroconvert to syphilis
over 14 months follow-up. Both men had been treated for syphilis within a week of the PCR test.
Conclusions: T pallidum PCR is a potentially powerful tool for the early diagnosis of primary syphilis, particularly
where a serological response has yet to develop.
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Background
Syphilis is a sexually transmissible infection (STI) caused
by Treponema pallidum. The infection is systemic, usu-
ally involving mucocutaneous ulcers and rashes in the
early phases, and a range of serious complications in-
cluding cardiovascular and neurological disease in later
phases [1,2].
As in many countries, Australian men who have sex
with men (MSM) with HIV infection are disproportion-
ately affected by syphilis. Although only ~10% of Austra-
lian MSM have HIV infection they contribute around
half of all cases of infectious syphilis among MSM [3,4].
Community-based cohort studies have shown that the
incidence of syphilis in MSM with HIV infection is 5–10
times higher than in MSM without HIV [5]. Reasons for
this differential are probably behavioural, [6]. but a bio-
logical phenomenon linked to HIV’s effect on the im-
mune system has yet to be excluded [7].
Syphilis is at its most infectious in its primary and sec-
ondary stages, so early detection has been modelled to
have the maximum benefit for preventing its onward
transmission [8]. The interpretation of syphilis serology
can be problematic in primary syphilis because sero-
logical responses might be delayed, often requiring the
patient to return for re-testing.
Dark-field microscopy of secretions from chancres can
provide a rapid point-of care test result, but the sensitiv-
ity is limited and the skill and meticulous care required
for specimen collection and microscopy are rarely avail-
able. The loss of expertise in dark-field microscopy was
lamented over 60 years ago [9].
HIV infection is more likely to be associated with
exaggerated and delayed serological responses to syphilis
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infection [10]. This problem can result in a syphilis diag-
nosis being missed or the treatment being delayed, with
ongoing transmission. A PCR based swab test has the
potential to provide earlier diagnosis of primary syphilis
in MSM with HIV and also demonstrate re-infection in
high titre rapid plasma reagin (RPR) serofast MSM with
HIV who have been previously treated for syphilis. Con-
sidering the high incidence of early syphilis in HIV-
infected MSM, a more sensitive and robust direct test
for T pallidum such as PCR is needed.
In this study we evaluated the performance of a probe
based PCR assay used to detect T pallidum in suspected
lesions of early syphilis, based on a comprehensive clin-
ical and serological assessment.
Methods
Study setting and population
Taylor Square Private Clinic was established in 1981 as
Australia’s first private sexual health clinic and has one
of the highest case-loads of HIV-infected MSM patients
in Australia [11]. All high-risk patients are routinely
screened for T pallidum, Chlamydia trachomatis, Neis-
seria gonorrhoeae and HIV according to guidelines [12].
All patients in this study were consecutive high-risk
MSM with lesions suggestive of early syphilis between
2004 and 2010, though in the early years of the study
the test was in limited supply so it was only used for the
highest-risk men. Heterosexual patients were excluded
because syphilis is rare in heterosexuals in Australian
cities. There was no standardized specimen collection
protocol and several different doctors collected specimens.
T pallidum PCR
Specimen collection
A dry swab specimen was obtained from genital, anal or
oral ulcers; or from the surface of rashes, papular
lesions, or mucosal erosions suggestive of secondary
syphilis; then placed in transport medium and sent at
room temperature to the Institute of Clinical Pathology
and Medical Research (ICPMR) for syphilis PCR testing.
Blood for syphilis serology was collected at the same
time.
DNA extraction
DNA was extracted from clinical specimens using the
NucliSENS easyMAG (BioMeurieux) total nucleic acid
extraction system with off board lysis. In brief, swabs
were placed in individual lysis tubes, vortexed vigorously
and incubated at room temperature for 10 minutes.
Lysis solution was then combined with magnetic silica in
an extraction cartridge and DNA extracted in the easy-
MAG using Boom technology. DNA extracts were
stored at −80°C prior to PCR testing.
Assay design
The T pallidum PCR targets a 146 base pair region of the
gene encoding the 47kDa lipoprotein (Genbank accession
number: M88769). The assay uses a 6 carboxyfluorescein
(FAM) labelled hydrolysis probe and end point fluores-
cence detection to identify amplification of products.
The primers [Syph1: 1130AGG GGA AGG TGC TGA
CCA TAG1150; & Syph2: 1275GGG AGT GAA ATC CGC
AGA GAG1255] and hydrolysis probe [1166(6-FAM) AGC
CTA AGC TTG TCA GCG ATC AAG C (BHQ1)1191]
were designed using Primer3 and manufactured by
Sigma Aldrich.
The PCR was performed in a 50uL reaction containing
sample DNA, 3.5mM MgCl2, 200nM each primer,
100nM probe & HotStar Taq Master Mix (Qiagen) [con-
taining 1.5mM MgCl2; 200uM each dNTP & HotStar
taq DNA polymerase]. Baseline fluorescence was deter-
mined using the FlourTracker (Stratagene) before ampli-
fication in a Eppendorf Mastercycler under the following
conditions: 95°C × 15 min; 50 cycles of [96°C × 10 sec,
60°C x 1min, 72C × 1min]; 72°C × 5min. Post amplifica-
tion fluorescence was again measured in the Fluor-
Tracker and the ratio of post- to pre-amplification
fluorescence calculated.
Samples with fluorescence ratios greater than 3.4 were
considered positive and confirmed by gel electrophoresis
on a 2% agarose gel run for 40 minutes at 200V. Fluores-
cence ratios less than 1.5 indicated a negative sample,
and samples with ratios between 1.5 and 3.4 were
deemed equivocal and the assay repeated.
Controls
Individual samples were tested in parallel with inhibition
and contamination controls and as both neat and diluted
DNA to ensure detection of both weak and strong speci-
mens. Inhibition controls consisted of sample DNA
spiked with positive material, while contamination con-
trols utilised no template reagent samples. Each run also
contained a serial dilution of positive control to identify
the limit of detection of the assay. The positive control
was produced by extraction of DNA from a T pallidum
(Nichols) suspension which had been previously used in
the T pallidum immobilization assay. Initial experiments
indicated the assay had a limit of detection of 10–100
organisms and was specific for T pallidum species.
Syphilis serology
Sera were initially screened with fully automated one-
step Immulite Treponemal EIA (Siemens Healthcare
Diagnostics) which uses one major T pallidum recom-
binant antigen (p17). Specimens positive by EIA were
then subjected to confirmatory testing with a RPR test
(Reditest, Biokit) and a T pallidum particle agglutination
assay (TPPA) (Serodia TPPA, Fujirebio) and fluorescent
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treponemal antibody absorption (FTA-ABS) test (MarDxW).
Men that had previously been treated for syphilis were
screened with the RPR test.
Narrow definition of a syphilis case
A MSM patient was classified as having primary or sec-
ondary syphilis if:
1. His serology was positive by EIA and TPPA at the
time of the PCR swab, after being negative in the
previous year, or
2. His RPR titre had risen 4-fold (two titres) or more if
he had previously been treated for syphilis.
However, as this definition excludes cases that are in
the serological window period, for this study we used a
broader case definition:
Broader definition of a syphilis case
A MSM patient was classified as having primary or sec-
ondary syphilis if he had consistent symptoms and signs
and:
1. His serology was positive by both the EIA and TPPA
at the time of the PCR swab or within 6 weeks of
treatment, after being negative in the previous year, or
2. His RPR titre rose 4-fold (two titres) or more if he
had previously been treated for syphilis.
This expanded (longitudinal) definition of early syph-
ilis was developed because many cases were treated pre-
sumptively (before serological confirmation) on clinical
suspicion or as soon as a positive PCR test result became
available. Direct detection tests such as dark-field mi-
croscopy [13] and PCR [14] for syphilis have been docu-
mented to sometimes precede the serological response,
as with all infections.
We conservatively settled on a 6-week cut-off as the
minimum period for someone to be (a) treated for syph-
ilis, (b) to have a long-acting injected penicillin or a 2-
week course of oral doxycycline ‘wash out’, (c) to become
newly-infected with syphilis, and (d) to thereafter mount
a serological response. Any seroconversion to syphilis
within 6 weeks was, therefore, deemed to result from a
T pallidum infection at the time of the initial swab col-
lection and treatment.
Uninfected case definition
A MSM patient was deemed to not have syphilis if the T
pallidum PCR test was negative and:
1. His T pallidum EIA test remained negative, or
2. His RPR titre did not rise 4-fold (two titres) or more
if he had previously been treated for syphilis.
Analysis
Clinical and laboratory data that were extracted from
the patient management system included HIV status,
syphilis stage, treatment, previous syphilis, syphilis ser-
ology and PCR results.
The performance (sensitivity and specificity) of the
Treponema pallidum PCR in lesions suggestive of pri-
mary syphilis and secondary syphilis was then assessed
against the definitions of a syphilis case (above), and by
HIV status. For the purpose of comparability with other
studies, we also assessed the performance of the PCR
test against the narrower definition of syphilis that was
limited to base-line clinical signs and serology. We cal-
culated 95% confidence intervals (CIs) using the bino-
mial approximation method.
Using a Chi-square test we compared the performance
of the PCR test in HIV-positive and HIV-negative men.
All analyses were conducted using Stata statistical soft-
ware version 9 [15].
Results
We collected swabs for T pallidum PCR testing from
260 MSM patients on 288 occasions over the 7-year
study period. Of the 288 specimens, 35.8% were col-
lected from penile ulcers, 36.1% from anal ulcers, 17.4%
from oral ulcers, 9% from rashes, 1.4% from snail track
ulcers of the mouth and 0.3% from perianal condylomata
lata (Table 1).
Performance of PCR against serology – broader definition
Using the broader case definition, 77 (26.7%) of the 288
PCR specimens were collected from men with primary
or secondary syphilis at baseline and 211 (73.3%) were
collected from men without syphilis.
Of the 55 men with primary syphilis, 49 were PCR
positive, yielding a sensitivity of 89.1% (95% CI: 77.8%-
95.9%) and a specificity of 99.1% (95% CI: 96.5%-99.9%).
Of the 22 men with secondary syphilis, 11 were PCR
positive, yielding a sensitivity of 50% (95% CI: 28.2%-
71.8%) a specificity of 100% (95% CI: 66.4%-100%)
(Table 1). By specimen type, the sensitivity was 90.9%
(95% CI: 75.7%-98.1%) in penile chancres, 100% (95%CI:
79.4%-100%) in anal chancres, 50% (95%CI: 11.8%-
88.2%) in oral chances, 35% (95%CI:14.2-61.7) in dry
rashes of secondary syphilis, and 100% in moist second-
ary lesions (snail track oral lesions and perianal condyl-
omata lata) (Table 1).
There was no significant difference in sensitivity and
specificity of the PCR test, nor site or stage of syphilis,
according to HIV status. Of the 77 syphilis cases, 43
(56%) were HIV positive, including 53.7% of the primary
cases and 62.5% of the secondary cases.
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Performance of PCR against serology – narrow case
definition
Using the narrow case definition, three MSM who were
TP PCR positive with primary syphilis who were initially
seronegative but later seroconverted to syphilis (cases 1–
3 in Table 2) were categorized as not having syphilis. This
exercise netted a slightly higher sensitivity of 94.2% (95%
CI: 84.1%-98.8%) than the broader case definition but a
slightly lower specificity of 97.6% (95% CI: 94.4%-99.1%).
Discrepant results– PCR positive and serology negative
In five high-risk MSM the T. pallidum PCR test was
positive and the syphilis serology was negative at base-
line. The characteristics of these cases, including follow-
up serology, are detailed in Table 2. Cases 1, 2, and 3 all
seroconverted to syphilis within 35 days. Case 4 serocon-
verted between 72 and 170 days and was at ongoing risk,
so it was not possible to determine whether he was a late
seroconverter or was re-infected with syphilis. Case 5
remained seronegative after 14 months and received
antibiotic treatment 7 days after sample collection. Both
cases 4 and 5 were HIV positive with high CD4 counts.
Notably, three men who seroconverted later, had not
previously been treated for syphilis and remained sero-
negative in the RPR test.
Discussion
We found the T pallidum PCR test to be both sensitive
and specific in primary syphilis, thus facilitating rapid
diagnosis and treatment. This evaluation has demon-
strated that the sensitivity of T. pallidum was 89.1% for
primary syphilis and 50.0% for secondary syphilis, in-
cluding three infections in men that seroconverted to
syphilis within five weeks. There was no difference in
the sensitivity and specificity of the PCR test according
to HIV status. The performance of T pallidum PCR test-
ing in our evaluation was broadly comparable to previ-
ous studies using other PCR tests [14,16-19].
Previous evaluations have generally relied on baseline
serology alone [16-18]. Clinicians are aware that the
diagnosis of syphilis is not so straightforward and recog-
nise that the diagnosis and staging of syphilis relies on a
Table 1 Performance of T pallidum PCR by syphilis stage and lesion site








Lesion stage Primary lesions(a) 49/55 89.1 (77.8-95.9) 200/202 99.1 (96.5-99.9)
Secondary lesions(b) 11/22 50.0 (28.2-71.8) 9/9 100.0 (66.4-100)
Lesion site Penile ulcer 30/33 90.9 (75.7-98.1) 68/70 97.1 (90.0-99.7)
Anal ulcer 16/16 100.0 (79.4-100) 88/88 100.0 (95.9-100*)
Oral ulcer 3/6 50.0 (11.8-88.2) 44/44 100.0 (91.9-100)
Generalised rash 6/17 35.3 (14.2-61.7) 9/9 100.0 (66.4-100)
Perianal condylomata
lata/snail track ulcers of the mouth
5/5 100.0 (47.8-100) - -
(a)=penile, anal and oral ulcers.
(b)= Generalised rash, perianal condylomata lata, and snail track ulcers of the mouth.
Table 2 Characteristics of patients that were PCR positive but seronegative for syphilis at baseline
Case
number




























1 Anus No N P N N 14 - 7 P/N//P/P Delayed
2 Penis and
perianal
Yes N P N P/N/P/P 5 - 21 P/1:4/P/P Delayed
3 Penis No N P N N 11 7, 14 35 P/N/P/P Delayed
4 Penis No P (774) P ND N 6 14,42,72 170 P/N/P/P Delayed or
re-infection
5 Anus No P (646) P N N 7 426 - - Persistent negative
at 14 months
N=negative, P=positive, ND=not done, PCR=polymerase chain reaction, RPR= rapid plasma reagin, TPHA= treponema pallidum haemagglutination,
FTA= fluorescent treponemal antibody, EIA=enzyme immunoassay, d=days, m=months.
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combination of knowledge of the individual’s past syph-
ilis history and sexual behaviour, clinical appearance,
and serological profile (including RPR titre and sero-
logical evolution), as well as direct detection techniques.
Like Heymans et al., [17] and Gayet-Ageron et al [16]
we do not see much value in T pallidum PCR testing in
suspected secondary syphilis. The sensitivity of PCR was
modest (Table 3) and the sensitivity of both RPR and
specific serological tests is virtually 100% in secondary
syphilis [10]. That said, the sensitivity of the PCR test
might be increased by improved specimen collection.
There was a time when well-selected secondary lesions
were lightly abraded with the edge of a large-bore needle
or a scalpel to extract serum for dark-field microscopy
[9] and this might also improve the sensitivity of PCR.
This re-visited method of specimen-collection would be
worth examining in future evaluations of T pallidum
PCR tests. Notably, a study that assessed the perform-
ance of PCR using skin biopsy specimens to diagnose
secondary syphilis found a higher sensitivity of 75% [19].
The lack of a standardised specimen collection proto-
col is a limitation of this study that may have reduced
the apparent sensitivity of the PCR test. Another limita-
tion of our study was that patient selection was not
according to a formal protocol. Since the PCR test was
in limited supply the test was used selectively and there-
fore we assume that the tested population was biased to-
ward the higher risk MSM within the clinic. This bias
might inflate the apparent specificity of the PCR test.
The PCR test seems likely to be most valuable in pri-
mary syphilis, where serology is more problematic than
in secondary syphilis. Since HIV infection is more likely
to be associated with exaggerated or delayed serological
responses to syphilis, a PCR test has the potential to
provide earlier diagnosis of primary syphilis in MSM
with HIV and also demonstrate re-infection in high titre
RPR serofast MSM with HIV who have been previously
treated for syphilis. There were five (10% of the primary)
cases in our evaluation where the PCR was positive and
the serology was negative at baseline. In three cases the
serology became positive between 7 and 35 days later.
Palmer et al. also found two patients who were positive
by PCR 12 and 21 days before seroconverting to syphilis,
both were HIV positive [14]. A further two of our
patients, who were HIV positive were not confirmed as
becoming seropositive as a result of the current episode,
though one was positive when next tested 7 months
later. Palmer et al., also found a positive PCR result in a
patient with HIV infection with consistently negative
syphilis serology. This patient received a 10 day course
of antibiotics one week after sampling. They hypothe-
sized the prompt antibiotic treatment coupled with the
patient’s immune dysfunction may have blunted a sero-
logical response to T pallidum [14].
Conclusion
In conclusion, our evaluation demonstrated that T palli-
dum PCR could allow earlier diagnosis of primary syph-
ilis, with potential clinical and public health benefits.
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